{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,5]],"date-time":"2026-08-05T03:08:55Z","timestamp":1785899335640,"version":"3.56.0"},"reference-count":32,"publisher":"SAGE Publications","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAD"],"published-print":{"date-parts":[[2021,5,4]]},"abstract":"<jats:p>Background: Parkinson\u2019s disease (PD) and Alzheimer\u2019s disease (AD) are the two most prevalent neurodegenerative diseases associated with age. Pathological studies have shown that these two diseases share a certain degree of neuropathological overlap. AD neuropathologic change contributes to cognitive impairment in PD. However, the impact of AD pathology on other clinical phenotypes in PD remains largely unknown. Objective: Herein we aimed to assess the impact of co-occurring AD neuropathologic change on the clinical phenotypes of PD. Methods: We examined 46 autopsy brains of PD patients and available clinical information to retrospectively assess the effects of comorbid AD pathology on dementia, hallucinations, and dyskinesia commonly seen in advanced PD. Results: AD neuropathology significantly increased the risk of hallucinations and dementia, but not dyskinesia in PD patients. Surprisingly, diffuse Lewy body pathology, but not AD pathology, was associated with the occurrence of dementia and hallucinations. Most importantly, we reported that the severity of neuronal loss in the locus coeruleus (LC), but not the severity of neuronal loss in the substantia nigra (SN), was associated with the occurrence of dyskinesia in advanced PD patients, while neither Lewy body scores in SN nor LC had significant effects. Conclusion: We show for the first time that neuronal loss in LC contributes to dyskinesia. Understanding the relationships between the two distinct pathologies and their relevant clinical phenotypes will be crucial in the development of effective disease-modifying therapies for PD.<\/jats:p>","DOI":"10.3233\/jad-210114","type":"journal-article","created":{"date-parts":[[2021,3,12]],"date-time":"2021-03-12T11:00:55Z","timestamp":1615546855000},"page":"201-207","source":"Crossref","is-referenced-by-count":14,"title":["Associations of Alzheimer\u2019s Disease Neuropathologic Changes with Clinical Presentations of Parkinson\u2019s Disease"],"prefix":"10.1177","volume":"81","author":[{"given":"Qiang","family":"Tong","sequence":"first","affiliation":[{"name":"Department of Neurology, the Affiliated Huaian First People\u2019s Hospital of Nanjing Medical University, Jiangsu, China"},{"name":"Division of Neuropathology, Department of Laboratory Medicine and Pathology, University of Minnesota Medical School, Minneapolis, MN, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liam","family":"Chen","sequence":"additional","affiliation":[{"name":"Division of Neuropathology, Department of Laboratory Medicine and Pathology, University of Minnesota Medical School, Minneapolis, MN, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"179","reference":[{"key":"10.3233\/JAD-210114_ref1","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1007\/s00401-015-1406-3","article-title":"Neuropathologically mixed Alzheimer\u2019s and Lewy body disease: Burden of pathological protein aggregates differs between clinical phenotypes","volume":"129","author":"Walker","year":"2015","journal-title":"Acta Neuropathol"},{"key":"10.3233\/JAD-210114_ref2","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.clinbiochem.2019.08.005","article-title":"Alzheimer\u2019s disease and other neurodegenerative dementias in comorbidity: A clinical and neuropathological overview","volume":"73","author":"Matej","year":"2019","journal-title":"Clin Biochem"},{"key":"10.3233\/JAD-210114_ref3","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1001\/jama.2019.22360","article-title":"Diagnosis and treatment of Parkinson disease: A review","volume":"323","author":"Armstrong","year":"2020","journal-title":"JAMA"},{"key":"10.3233\/JAD-210114_ref4","doi-asserted-by":"crossref","first-page":"444","DOI":"10.4172\/2161-0460.1000444","article-title":"The contribution of tau, amyloid-beta and alpha-synuclein pathology to dementia in Lewy body disorders","volume":"8","author":"Irwin","year":"2018","journal-title":"J Alzheimers Dis Parkinsonism"},{"key":"10.3233\/JAD-210114_ref5","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1002\/ana.25392","article-title":"Cognitive and pathological influences of tau pathology in Lewy body disorders","volume":"85","author":"Coughlin","year":"2019","journal-title":"Ann Neurol"},{"key":"10.3233\/JAD-210114_ref6","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/0022-3956(75)90026-6","article-title":"\u201cMini-mental state\u201d. A practical method for grading the cognitive state of patients for the clinician","volume":"12","author":"Folstein","year":"1975","journal-title":"J Psychiatr Res"},{"key":"10.3233\/JAD-210114_ref7","doi-asserted-by":"crossref","first-page":"1689","DOI":"10.1002\/mds.21507","article-title":"Clinical diagnostic criteria for dementia associated with Parkinson\u2019s disease","volume":"22","author":"Emre","year":"2007","journal-title":"Mov Disord"},{"key":"10.3233\/JAD-210114_ref8","doi-asserted-by":"crossref","first-page":"1863","DOI":"10.1212\/01.wnl.0000187889.17253.b1","article-title":"Diagnosis and management of dementia with Lewy bodies: Third report of the DLB Consortium","volume":"65","author":"McKeith","year":"2005","journal-title":"Neurology"},{"key":"10.3233\/JAD-210114_ref9","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/j.jalz.2011.03.005","article-title":"The diagnosis of dementia due to Alzheimer\u2019s disease: Recommendations from the National Institute on Aging-Alzheimer\u2019s Association workgroups on diagnostic guidelines for Alzheimer\u2019s disease","volume":"7","author":"McKhann","year":"2011","journal-title":"Alzheimers Dement"},{"key":"10.3233\/JAD-210114_ref10","doi-asserted-by":"crossref","first-page":"2970","DOI":"10.1172\/JCI85456","article-title":"Activation of tyrosine kinase c-Abl contributes to alpha-synuclein-induced neurodegeneration","volume":"126","author":"Brahmachari","year":"2016","journal-title":"J Clin Invest"},{"key":"10.3233\/JAD-210114_ref11","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1007\/s00401-006-0127-z","article-title":"Staging of Alzheimer disease-associated neurofibrillary pathology using paraffin sections and immunocytochemistry","volume":"112","author":"Braak","year":"2006","journal-title":"Acta Neuropathol"},{"key":"10.3233\/JAD-210114_ref12","doi-asserted-by":"crossref","first-page":"1791","DOI":"10.1212\/WNL.58.12.1791","article-title":"Phases of A beta-deposition in the human brain and its relevance for the development of AD","volume":"58","author":"Thal","year":"2002","journal-title":"Neurology"},{"key":"10.3233\/JAD-210114_ref13","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1212\/WNL.41.4.479","article-title":"The Consortium to Establish a Registry for Alzheimer\u2019s Disease (CERAD). Part II. Standardization of the neuropathologic assessment of Alzheimer\u2019s disease","volume":"41","author":"Mirra","year":"1991","journal-title":"Neurology"},{"key":"10.3233\/JAD-210114_ref14","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s00401-011-0910-3","article-title":"National Institute on Aging-Alzheimer\u2019s Association guidelines for the neuropathologic assessment of Alzheimer\u2019s disease: A practical approach","volume":"123","author":"Montine","year":"2012","journal-title":"Acta Neuropathol"},{"key":"10.3233\/JAD-210114_ref15","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1212\/WNL.0b013e3181b01077","article-title":"The Nun study: Clinically silent AD, neuronal hypertrophy, and linguistic skills in early life","volume":"73","author":"Iacono","year":"2009","journal-title":"Neurology"},{"key":"10.3233\/JAD-210114_ref16","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1002\/ana.23659","article-title":"Neuropathologic substrates of Parkinson disease dementia","volume":"72","author":"Irwin","year":"2012","journal-title":"Ann Neurol"},{"key":"10.3233\/JAD-210114_ref17","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1038\/nrn3549","article-title":"Parkinson\u2019s disease dementia: Convergence of \u03b1-synuclein, tau and amyloid-\u03b2 pathologies","volume":"14","author":"Irwin","year":"2013","journal-title":"Nat Rev Neurosci"},{"key":"10.3233\/JAD-210114_ref18","doi-asserted-by":"crossref","first-page":"1201","DOI":"10.1136\/jnnp-2019-321913","article-title":"Evidence-based prevention of Alzheimer\u2019s disease: Systematic review and meta-analysis of 243 observational prospective studies and 153 randomised controlled trials","volume":"91","author":"Yu","year":"2020","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.3233\/JAD-210114_ref19","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1093\/brain\/awf033","article-title":"Visual hallucinations in Lewy body disease relate to Lewy bodies in the temporal lobe","volume":"125","author":"Harding","year":"2002","journal-title":"Brain"},{"key":"10.3233\/JAD-210114_ref20","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1002\/ana.25364","article-title":"Levodopa-induced dyskinesia in Parkinson disease: Current and evolving concepts","volume":"84","author":"Espay","year":"2018","journal-title":"Ann Neurol"},{"key":"10.3233\/JAD-210114_ref21","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1111\/jnc.12751","article-title":"Dyskinesia in Parkinson\u2019s disease: Mechanisms and current non-pharmacological interventions","volume":"130","author":"Heumann","year":"2014","journal-title":"J Neurochem"},{"key":"10.3233\/JAD-210114_ref22","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1007\/s00441-017-2649-1","article-title":"Locus coeruleus","volume":"373","author":"Benarroch","year":"2018","journal-title":"Cell Tissue Res"},{"key":"10.3233\/JAD-210114_ref23","doi-asserted-by":"crossref","first-page":"1006","DOI":"10.4103\/1673-5374.270297","article-title":"Locus coeruleus-norepinephrine: Basic functions and insights into Parkinson\u2019s disease","volume":"15","author":"Bari","year":"2020","journal-title":"Neural Regen Res"},{"key":"10.3233\/JAD-210114_ref24","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.neuint.2016.11.009","article-title":"Targeting the norepinephrinergic system in Parkinson\u2019s disease and related disorders: The locus coeruleus story","volume":"102","author":"Vermeiren","year":"2017","journal-title":"Neurochem Int"},{"key":"10.3233\/JAD-210114_ref25","doi-asserted-by":"crossref","first-page":"435","DOI":"10.3389\/fphar.2020.00435","article-title":"The noradrenergic system in Parkinson\u2019s disease","volume":"11","author":"Paredes-Rodriguez","year":"2020","journal-title":"Front Pharmacol"},{"key":"10.3233\/JAD-210114_ref26","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1016\/j.pbb.2011.09.009","article-title":"Effects of noradrenergic denervation on L-DOPA-induced dyskinesia and its treatment by \u03b1- and \u03b2-adrenergic receptor antagonists in hemiparkinsonian rats","volume":"100","author":"Barnum","year":"2012","journal-title":"Pharmacol Biochem Behav"},{"key":"10.3233\/JAD-210114_ref27","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.expneurol.2014.04.011","article-title":"Noradrenaline neuron degeneration contributes to motor impairments and development of L-DOPA-induced dyskinesia in a rat model of Parkinson\u2019s disease","volume":"257","author":"Shin","year":"2014","journal-title":"Exp Neurol"},{"key":"10.3233\/JAD-210114_ref28","doi-asserted-by":"crossref","first-page":"e24679","DOI":"10.1371\/journal.pone.0024679","article-title":"The locus coeruleus is directly implicated in L-DOPA-induced dyskinesia in parkinsonian rats: An electrophysiological and behavioural study","volume":"6","author":"Miguelez","year":"2011","journal-title":"PLoS One"},{"key":"10.3233\/JAD-210114_ref29","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.neuint.2018.01.010","article-title":"Striatal norepinephrine efflux in l-DOPA-induced dyskinesia","volume":"114","author":"Ostock","year":"2018","journal-title":"Neurochem Int"},{"key":"10.3233\/JAD-210114_ref30","doi-asserted-by":"crossref","first-page":"1257","DOI":"10.1007\/s00702-009-0291-0","article-title":"Effect of the additional noradrenergic neurodegeneration to 6-OHDA-lesioned rats in levodopa-induced dyskinesias and in cognitive disturbances","volume":"116","author":"Perez","year":"2009","journal-title":"J Neural Transm (Vienna)"},{"key":"10.3233\/JAD-210114_ref31","doi-asserted-by":"crossref","first-page":"13804","DOI":"10.1073\/pnas.0702753104","article-title":"Norepinephrine loss produces more profound motor deficits than MPTP treatment in mice","volume":"104","author":"Rommelfanger","year":"2007","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.3233\/JAD-210114_ref32","doi-asserted-by":"crossref","first-page":"2586","DOI":"10.1046\/j.1460-9568.2003.02684.x","article-title":"Potentiation of parkinsonian symptoms by depletion of locus coeruleus noradrenaline in 6-hydroxydopamine-induced partial degeneration of substantia nigra in rats","volume":"17","author":"Srinivasan","year":"2003","journal-title":"Eur J Neurosci"}],"container-title":["Journal of Alzheimer's Disease"],"original-title":[],"link":[{"URL":"https:\/\/content.iospress.com\/download?id=10.3233\/JAD-210114","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T10:05:31Z","timestamp":1777370731000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.sagepub.com\/doi\/full\/10.3233\/JAD-210114"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,5,4]]},"references-count":32,"journal-issue":{"issue":"1"},"URL":"https:\/\/doi.org\/10.3233\/jad-210114","relation":{},"ISSN":["1387-2877","1875-8908"],"issn-type":[{"value":"1387-2877","type":"print"},{"value":"1875-8908","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,5,4]]}}}